MTOPS, AUA guidelines continue to shape BPH Tx


Dallas--The two most significant developments in the management of benignprostatic hyperplasia in the past year were the release of the AUA updateof clinical guidelines for the condition and analysis of data from the MedicalTherapy of Prostatic Symptoms (MTOPS) trial, said Claus G. Roehrborn, MD,professor and chairman of the department of urology, University of TexasSouthwestern Medical Center, Dallas.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.